ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

1

April 29, 2022

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST

This file is intended as a reference file for ICD-O-3 only and is not to be used for casefinding purposes. The ICD-O-3 site/type validation program was modified to allow only for the site/histology/behavior combinations listed in this publication. All other cases must be reviewed. Submit any comments or questions about this document to: Ask A SEER Registrar https://seer.cancer.gov/registrars/contact.html
or
seerweb@imsweb.com

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

2

LIP C000-C006,C008-C009 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

3

LIP C000-C006,C008-C009 LYMPHOEPITHELIAL CARCINOMA
ADENOCARCINOMA, NOS
ADENOID CYSTIC & CRIBRIFORM CA. BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA NEVI & MELANOMAS
AMELANOTIC MELANOMA MAL. MEL. IN JUNCT. NEVUS EPITHELIOID CELL MELANOMA

808 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
873 8730/3 Amelanotic melanoma
874 8743/3 Superficial spreading melanoma 8745/3 Desmoplastic melanoma, malignant 8746/3 Mucosal lentiginous melanoma
877 8770/3 Mixed epithel. & spindle cell melanoma 8771/3 Epithelioid cell melanoma 8772/3 Spindle cell melanoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

4

LIP C000-C006,C008-C009 MIXED TUMOR, MALIGNANT, NOS
KAPOSI SARCOMA FOLLIC. & MARGINAL LYMPH, NOS LYMPHOID LEUKEMIA, NOS

894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
914 9140/3 Kaposi sarcoma
969 9699/3 Marginal zone B-cell lymphoma, NOS
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

5

BASE OF TONGUE C019 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

6

BASE OF TONGUE C019 LYMPHOEPITHELIAL CARCINOMA
ADENOCARCINOMA, NOS
ADENOID CYSTIC & CRIBRIFORM CA. BRONCHIOLO-ALVEOLAR ADENOCA. MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA
NEVI & MELANOMAS
SARCOMA, NOS RHABDOMYOSARCOMA, NOS

808 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type 8085/3 Squamous cell carcinoma, HPV-positive 8086/3 Squamous cell carcinoma, HPV-negative
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
825 8255/3 Adenocarcinoma with mixed subtypes
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS
872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
882 8825/3 Myofibroblastic sarcoma
890 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

7

BASE OF TONGUE C019 EMBRYONAL RHABDOMYOSARCOMA MIXED TUMOR, MALIGNANT, NOS KAPOSI SARCOMA MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS

891 8910/3 Embryonal rhabdomyosarcoma 8912/3 Spindle cell rhabdomyosarcoma
894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
914 9140/3 Kaposi sarcoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

8

BASE OF TONGUE C019 T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS

970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

9

BASE OF TONGUE C019 PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

10

TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

11

TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029 LYMPHOEPITHELIAL CARCINOMA
ADENOCARCINOMA, NOS
ADENOID CYSTIC & CRIBRIFORM CA. BRONCHIOLO-ALVEOLAR ADENOCA. MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA
NEVI & MELANOMAS
SARCOMA, NOS RHABDOMYOSARCOMA, NOS

808 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
825 8255/3 Adenocarcinoma with mixed subtypes
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS
872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
882 8825/3 Myofibroblastic sarcoma
890 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

12

TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029 EMBRYONAL RHABDOMYOSARCOMA MIXED TUMOR, MALIGNANT, NOS KAPOSI SARCOMA MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS

891 8910/3 Embryonal rhabdomyosarcoma 8912/3 Spindle cell rhabdomyosarcoma
894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
914 9140/3 Kaposi sarcoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

13

TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029 T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS

970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

14

TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029 PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

15

GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069

NEOPLASM

800 8000/3

8001/3

8002/3

8003/3

8004/3

8005/3

Neoplasm, malignant Tumor cells, malignant Malignant tumor, small cell type Malignant tumor, giant cell type Malignant tumor, spindle cell type Malignant tumor, clear cell type

CARCINOMA, NOS

801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS

802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA

803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS

805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS

807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

16

GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069

LYMPHOEPITHELIAL CARCINOMA

808 8081/2

8082/3

8083/3

8084/3

Bowen disease Lymphoepithelial carcinoma Basaloid squamous cell carcinoma Squamous cell carcinoma, clear cell type

ADENOCARCINOMA, NOS

814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA.

820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA.

825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS

826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS

831 8310/3 Clear cell adenocarcinoma, NOS

MUCOEPIDERMOID CARCINOMA

843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS

844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA

848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma

ACINAR CELL CARCINOMA

855 8550/3 Acinar cell carcinoma 8551/3 Acinar cell cystadenocarcinoma

NEVI & MELANOMAS

872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA

873 8730/3 Amelanotic melanoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

17

GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069

MAL. MEL. IN JUNCT. NEVUS

874 8743/3

8745/3

8746/3

Superficial spreading melanoma Desmoplastic melanoma, malignant Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA

877 8770/3 Mixed epithel. & spindle cell melanoma 8771/3 Epithelioid cell melanoma 8772/3 Spindle cell melanoma, NOS

FIBROMATOUS NEOPLASMS

881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS

882 8825/3 Myofibroblastic sarcoma

RHABDOMYOSARCOMA, NOS

890 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA

891 8910/3 Embryonal rhabdomyosarcoma 8912/3 Spindle cell rhabdomyosarcoma

MIXED TUMOR, MALIGNANT, NOS

894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS

898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma

KAPOSI SARCOMA

914 9140/3 Kaposi sarcoma

MALIGNANT LYMPHOMA, NOS

959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA

965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

18

GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069

HODGKIN LYMPHOMA, NOD. SCLER.

966 9661/3

9662/3

9663/3

9664/3

9665/3

9667/3

Hodgkin granuloma [obs] Hodgkin sarcoma [obs] Hodgkin lymphoma, nodular sclerosis, NOS Hodgkin lymphoma, nod. scler., cellular phase Hodgkin lymphoma, nod. scler., grade 1 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC

967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE

968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS

969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS

970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA

971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH.

972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS

973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma

MAST CELL TUMORS

974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

19

GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS

975 9750/3

9751/3

9754/3

9755/3

9756/3

9757/3

9758/3

9759/3

Malignant histiocytosis Langerhans cell histiocytosis, NOS Langerhans cell histiocytosis, disseminated Histiocytic sarcoma Langerhans cell sarcoma Interdigitating dendritic cell sarcoma Follicular dendritic cell sarcoma Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES

976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS

981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS

982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA

983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS.

996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

20

SALIVARYGLAND C079-C081,C088-C089 NEOPLASM CARCINOMA, NOS CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS
LYMPHOEPITHELIAL CARCINOMA

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation
808 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

21

SALIVARYGLAND C079-C081,C088-C089 ADENOCARCINOMA, NOS
TRABECULAR ADENOCARCINOMA ADENOID CYSTIC & CRIBRIFORM CA.
SOLID CARCINOMA, NOS
BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
OXYPHILIC ADENOCARCINOMA CLEAR CELL ADENOCARCINOMA, NOS MUCOEPIDERMOID CARCINOMA CYSTADENOCARCINOMA, NOS MUCINOUS ADENOCARCINOMA DUCT CARCINOMA LOBULAR AND OTHER DUCTAL CA. ACINAR CELL CARCINOMA

814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
819 8190/3 Trabecular adenocarcinoma
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
823 8230/2 Duct carcinoma in situ, solid type 8230/3 Solid carcinoma, NOS 8231/3 Carcinoma simplex
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
829 8290/3 Oxyphilic adenocarcinoma
831 8310/3 Clear cell adenocarcinoma, NOS
843 8430/3 Mucoepidermoid carcinoma
844 8440/3 Cystadenocarcinoma, NOS
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
850 8500/3 Invasive carcinoma of no special type 8502/3 Secretory carcinoma of no special type
852 8525/3 Polymorphous low grade adenocarcinoma
855 8550/3 Acinar cell carcinoma 8551/3 Acinar cell cystadenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

22

SALIVARYGLAND C079-C081,C088-C089 ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA
SARCOMA, NOS
FIBROMATOUS NEOPLASMS SARCOMA, NOS MYXOSARCOMA LIPOSARCOMA NEOPLASMS
MYOMATOUS NEOPLASMS

856 8560/3 Adenosquamous carcinoma 8561/3 Warthin tumor, malignant 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant
882 8825/3 Myofibroblastic sarcoma
884 8840/3 Myxosarcoma
885 8850/3 Liposarcoma, NOS 8851/3 Liposarcoma, well differentiated 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed type liposarcoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

23

SALIVARYGLAND C079-C081,C088-C089 RHABDOMYOSARCOMA, NOS EMBRYONAL RHABDOMYOSARCOMA MIXED TUMOR, MALIGNANT, NOS CARCINOSARCOMA, NOS MESENCHYMOMA, MALIGNANT KAPOSI SARCOMA MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC

890 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma
891 8910/3 Embryonal rhabdomyosarcoma 8912/3 Spindle cell rhabdomyosarcoma
894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
899 8990/3 Mesenchymoma, malignant 8991/3 Embryonal sarcoma
914 9140/3 Kaposi sarcoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

24

SALIVARYGLAND C079-C081,C088-C089 ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES

968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

25

SALIVARYGLAND C079-C081,C088-C089 PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

26

OROPHARNYX C090-C091,C098-C104,C108-C109 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

27

OROPHARNYX C090-C091,C098-C104,C108-C109 LYMPHOEPITHELIAL CARCINOMA
TRANSITIONAL CELL CARCINOMA, NOS
ADENOCARCINOMA, NOS
ADENOID CYSTIC & CRIBRIFORM CA. BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA NEVI & MELANOMAS
AMELANOTIC MELANOMA

808 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type 8085/3 Squamous cell carcinoma, HPV-positive 8086/3 Squamous cell carcinoma, HPV-negative
812 8120/2 Transitional cell carcinoma in situ 8120/3 Transitional cell carcinoma, NOS 8121/3 Schneiderian carcinoma 8122/3 Trans. cell carcinoma, spindle cell 8123/3 Basaloid carcinoma 8124/3 Cloacogenic carcinoma
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
873 8730/3 Amelanotic melanoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

28

OROPHARNYX C090-C091,C098-C104,C108-C109 MAL. MEL. IN JUNCT. NEVUS MAL. MELAN. IN GIANT PIGMT. NEVUS EPITHELIOID CELL MELANOMA SARCOMA, NOS
LIPOSARCOMA NEOPLASMS
RHABDOMYOSARCOMA, NOS EMBRYONAL RHABDOMYOSARCOMA MIXED TUMOR, MALIGNANT, NOS CARCINOSARCOMA, NOS KAPOSI SARCOMA

874 8743/3 Superficial spreading melanoma 8745/3 Desmoplastic melanoma, malignant 8746/3 Mucosal lentiginous melanoma
876 8761/3 Mal. melanoma in giant pigmented nevus
877 8770/3 Mixed epithel. & spindle cell melanoma 8771/3 Epithelioid cell melanoma 8772/3 Spindle cell melanoma, NOS
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
885 8850/3 Liposarcoma, NOS 8851/3 Liposarcoma, well differentiated 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed type liposarcoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma
890 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma
891 8910/3 Embryonal rhabdomyosarcoma 8912/3 Spindle cell rhabdomyosarcoma
894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
914 9140/3 Kaposi sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

29

OROPHARNYX C090-C091,C098-C104,C108-C109 MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA

959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

30

OROPHARNYX C090-C091,C098-C104,C108-C109 PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS
MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

31

NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

32

NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119 LYMPHOEPITHELIAL CARCINOMA TRANSITIONAL CELL CARCINOMA, NOS
ADENOCARCINOMA, NOS
ADENOID CYSTIC & CRIBRIFORM CA. BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
CLEAR CELL ADENOCARCINOMA, NOS MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA NEVI & MELANOMAS
AMELANOTIC MELANOMA

808 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type
812 8120/2 Transitional cell carcinoma in situ 8120/3 Transitional cell carcinoma, NOS 8121/3 Schneiderian carcinoma 8122/3 Trans. cell carcinoma, spindle cell 8123/3 Basaloid carcinoma 8124/3 Cloacogenic carcinoma
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
831 8310/3 Clear cell adenocarcinoma, NOS
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
873 8730/3 Amelanotic melanoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

33

NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119 MAL. MEL. IN JUNCT. NEVUS EPITHELIOID CELL MELANOMA SARCOMA, NOS
FIBROMATOUS NEOPLASMS
SARCOMA, NOS RHABDOMYOSARCOMA, NOS EMBRYONAL RHABDOMYOSARCOMA MIXED TUMOR, MALIGNANT, NOS CARCINOSARCOMA, NOS EMBRYONAL CARCINOMA, NOS KAPOSI SARCOMA

874 8743/3 Superficial spreading melanoma 8745/3 Desmoplastic melanoma, malignant 8746/3 Mucosal lentiginous melanoma
877 8770/3 Mixed epithel. & spindle cell melanoma 8771/3 Epithelioid cell melanoma 8772/3 Spindle cell melanoma, NOS
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant
882 8825/3 Myofibroblastic sarcoma
890 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma
891 8910/3 Embryonal rhabdomyosarcoma 8912/3 Spindle cell rhabdomyosarcoma
894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
907 9070/3 Embryonal carcinoma, NOS 9071/3 Yolk sac tumor 9072/3 Polyembryoma
914 9140/3 Kaposi sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

34

NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119 CHORDOMA MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS

937 9370/3 Chordoma, NOS 9371/3 Chondroid chordoma 9372/3 Dedifferentiated chordoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

35

NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119 OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA

971 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

36

NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119 CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

37

POSTERIOR WALL OF NASOPHARYNX C111 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

38

POSTERIOR WALL OF NASOPHARYNX C111 LYMPHOEPITHELIAL CARCINOMA
TRANSITIONAL CELL CARCINOMA, NOS
ADENOCARCINOMA, NOS
ADENOID CYSTIC & CRIBRIFORM CA. BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
CLEAR CELL ADENOCARCINOMA, NOS MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA NEVI & MELANOMAS
AMELANOTIC MELANOMA

808 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type 8085/3 Squamous cell carcinoma, HPV-positive 8086/3 Squamous cell carcinoma, HPV-negative
812 8120/2 Transitional cell carcinoma in situ 8120/3 Transitional cell carcinoma, NOS 8121/3 Schneiderian carcinoma 8122/3 Trans. cell carcinoma, spindle cell 8123/3 Basaloid carcinoma 8124/3 Cloacogenic carcinoma
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
831 8310/3 Clear cell adenocarcinoma, NOS
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
873 8730/3 Amelanotic melanoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

39

POSTERIOR WALL OF NASOPHARYNX C111 MAL. MEL. IN JUNCT. NEVUS EPITHELIOID CELL MELANOMA SARCOMA, NOS
FIBROMATOUS NEOPLASMS
SARCOMA, NOS RHABDOMYOSARCOMA, NOS EMBRYONAL RHABDOMYOSARCOMA MIXED TUMOR, MALIGNANT, NOS CARCINOSARCOMA, NOS EMBRYONAL CARCINOMA, NOS KAPOSI SARCOMA

874 8743/3 Superficial spreading melanoma 8745/3 Desmoplastic melanoma, malignant 8746/3 Mucosal lentiginous melanoma
877 8770/3 Mixed epithel. & spindle cell melanoma 8771/3 Epithelioid cell melanoma 8772/3 Spindle cell melanoma, NOS
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant
882 8825/3 Myofibroblastic sarcoma
890 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma
891 8910/3 Embryonal rhabdomyosarcoma 8912/3 Spindle cell rhabdomyosarcoma
894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
907 9070/3 Embryonal carcinoma, NOS 9071/3 Yolk sac tumor 9072/3 Polyembryoma
914 9140/3 Kaposi sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

40

POSTERIOR WALL OF NASOPHARYNX C111 CHORDOMA MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA

937 9370/3 Chordoma, NOS 9371/3 Chondroid chordoma 9372/3 Dedifferentiated chordoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9719/3 NK/T-cell lymphoma, nasal and nasal-type

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

41

POSTERIOR WALL OF NASOPHARYNX C111 PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

42

HYPOPHARYNX C129-C132,C138-C139 NEOPLASM CARCINOMA, NOS CARCINOMA, UNDIFF., NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS
LYMPHOEPITHELIAL CARCINOMA TRANSITIONAL CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation
808 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type
812 8120/2 Transitional cell carcinoma in situ 8120/3 Transitional cell carcinoma, NOS 8121/3 Schneiderian carcinoma 8122/3 Trans. cell carcinoma, spindle cell 8123/3 Basaloid carcinoma 8124/3 Cloacogenic carcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

43

HYPOPHARYNX C129-C132,C138-C139 ADENOCARCINOMA, NOS
ADENOID CYSTIC & CRIBRIFORM CA.
BRONCHIOLO-ALVEOLAR ADENOCA. MUCOEPIDERMOID CARCINOMA FIBROMATOUS NEOPLASMS
SARCOMA, NOS MIXED TUMOR, MALIGNANT, NOS CARCINOSARCOMA, NOS
KAPOSI SARCOMA MALIGNANT LYMPHOMA, NOS
HODGKIN LYMPHOMA

814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
825 8255/3 Adenocarcinoma with mixed subtypes
843 8430/3 Mucoepidermoid carcinoma
881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant
882 8825/3 Myofibroblastic sarcoma
894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
914 9140/3 Kaposi sarcoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

44

HYPOPHARYNX C129-C132,C138-C139 HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS

966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

45

HYPOPHARYNX C129-C132,C138-C139 MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

46

PHARYNX C140,C142,C148 NEOPLASM CARCINOMA, NOS CARCINOMA, UNDIFF., NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS
LYMPHOEPITHELIAL CARCINOMA ADENOCARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation
808 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

47

PHARYNX C140,C142,C148 ADENOID CYSTIC & CRIBRIFORM CA. BRONCHIOLO-ALVEOLAR ADENOCA. MUCOEPIDERMOID CARCINOMA MYOMATOUS NEOPLASMS
MIXED TUMOR, MALIGNANT, NOS CARCINOSARCOMA, NOS CHORDOMA MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.

820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
825 8255/3 Adenocarcinoma with mixed subtypes
843 8430/3 Mucoepidermoid carcinoma
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
894 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
937 9370/3 Chordoma, NOS 9371/3 Chondroid chordoma 9372/3 Dedifferentiated chordoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

48

PHARYNX C140,C142,C148 ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS

967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

49

PHARYNX C140,C142,C148 NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

975 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

50

ESOPHAGUS C150-C155,C158-C159 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell 8045/3 Combined small cell carcinoma
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

51

ESOPHAGUS C150-C155,C158-C159 LYMPHOEPITHELIAL CARCINOMA ADENOCARCINOMA, NOS
ENDOCRINOMAS ADENOID CYSTIC & CRIBRIFORM CA. CARCINOID TUMOR, MALIGNANT
BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA

808 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8145/3 Carcinoma, diffuse type 8147/3 Basal cell adenocarcinoma
815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
820 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma
824 8240/3 Carcinoid tumor, malignant 8244/3 Composite carcinoid 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

52

ESOPHAGUS C150-C155,C158-C159 NEVI & MELANOMAS
AMELANOTIC MELANOMA MAL. MEL. IN JUNCT. NEVUS EPITHELIOID CELL MELANOMA MYOMATOUS NEOPLASMS
CARCINOSARCOMA, NOS ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA
PRECURS. CELL LYMPHOBLASTIC LYMPH.

872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
873 8730/3 Amelanotic melanoma
874 8743/3 Superficial spreading melanoma 8745/3 Desmoplastic melanoma, malignant 8746/3 Mucosal lentiginous melanoma
877 8770/3 Mixed epithel. & spindle cell melanoma 8771/3 Epithelioid cell melanoma 8772/3 Spindle cell melanoma, NOS
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
968 9680/3 ML, large B-cell, diffuse 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

53

ESOPHAGUS C150-C155,C158-C159 PLASMA CELL TUMORS
MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

54

STOMACH C160-C166,C168-C169 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

55

STOMACH C160-C166,C168-C169 ADENOCARCINOMA, NOS
ENDOCRINOMAS ADENOCA. IN ADENOMA. POLYP ADENOCA IN FAMIL POLYP COLI SOLID CARCINOMA, NOS CARCINOID TUMOR, MALIGNANT
BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS

814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8142/3 Linitis plastica 8143/3 Superficial spreading adenocarcinoma 8144/2 Intestinal-type adenoma, high grade 8144/3 Adenocarcinoma, intestinal type 8145/3 Carcinoma, diffuse type 8147/3 Basal cell adenocarcinoma
815 8153/3 Gastrinoma, malignant 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm 8156/3 Somatostatinoma, malignant
821 8210/2 Adenocarcinoma in situ in adenomatous polyp 8210/3 Adenocarcinoma in adenomatous polyp 8211/3 Tubular adenocarcinoma 8213/2 Serrated dysplasia, high grade 8214/3 Parietal cell carcinoma
822 8220/2 Adenocarcinoma in situ in familial polyp. coli 8220/3 Adenocarcinoma in adenoma. polyposis coli 8221/2 Adenocarc. in situ in mult. adenomatous polyps 8221/3 Adenocarcinoma in mult. adenomatous polyps
823 8230/2 Duct carcinoma in situ, solid type 8230/3 Solid carcinoma, NOS 8231/3 Carcinoma simplex
824 8240/3 Carcinoid tumor, malignant 8241/3 Enterochromaffin cell carcinoid 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8244/3 Composite carcinoid 8245/3 Adenocarcinoid tumor 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

56

STOMACH C160-C166,C168-C169 CLEAR CELL ADENOCARCINOMA, NOS MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA SIGNET RING CELL CARCINOMA MEDULLARY CARCINOMA, NOS ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA
SARCOMA, NOS
MYOMATOUS NEOPLASMS
STROMAL SARCOMA HEPATOBLASTOMA

831 8310/3 Clear cell adenocarcinoma, NOS
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
849 8490/3 Signet ring cell carcinoma
851 8510/3 Medullary carcinoma, NOS 8512/3 Medullary carcinoma with lymphoid stroma
856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
893 8934/3 Carcinofibroma 8935/3 Stromal sarcoma, NOS 8936/3 Gastrointestinal stromal sarcoma
897 8976/3 Gastroblastoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

57

STOMACH C160-C166,C168-C169 CARCINOSARCOMA, NOS MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS

898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

58

STOMACH C160-C166,C168-C169 OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS

971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9732/3 Multiple myeloma 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

59

STOMACH C160-C166,C168-C169 PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

60

SMALL INTESTINE C170-C173,C178-C179 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS ADENOCARCINOMA, NOS
ENDOCRINOMAS CHOLANGIOCARCINOMA

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8144/2 Intestinal-type adenoma, high grade 8144/3 Adenocarcinoma, intestinal type 8145/3 Carcinoma, diffuse type 8147/3 Basal cell adenocarcinoma
815 8152/3 Glucagonoma, malignant 8153/3 Gastrinoma, malignant 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm 8156/3 Somatostatinoma, malignant 8157/3 Enteroglucagonoma, malignant
816 8163/3 Pancreatobiliary-type carcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

61

SMALL INTESTINE C170-C173,C178-C179 ADENOCA. IN ADENOMA. POLYP CARCINOID TUMOR, MALIGNANT
BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
MUCINOUS ADENOCARCINOMA SIGNET RING CELL CARCINOMA MEDULLARY CARCINOMA, NOS ADENOCA. WITH METAPLASIA
EXTRA-ADRENAL PARAGANG., MAL GLOMANGIOSARCOMA SARCOMA, NOS

821 8211/3 Tubular adenocarcinoma 8213/2 Serrated dysplasia, high grade
824 8240/3 Carcinoid tumor, malignant 8241/3 Enterochromaffin cell carcinoid 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8244/3 Composite carcinoid 8245/3 Adenocarcinoid tumor 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
849 8490/3 Signet ring cell carcinoma
851 8510/3 Medullary carcinoma, NOS
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma
869 8693/3 Extra-adrenal paraganglioma, malignant
871 8710/3 Glomangiosarcoma
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

62

SMALL INTESTINE C170-C173,C178-C179 FIBROMATOUS NEOPLASMS
SARCOMA, NOS LIPOSARCOMA NEOPLASMS
MYOMATOUS NEOPLASMS
STROMAL SARCOMA MESENCHYMOMA, MALIGNANT MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA

881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant
882 8825/3 Myofibroblastic sarcoma
885 8850/3 Liposarcoma, NOS 8851/3 Liposarcoma, well differentiated 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed type liposarcoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
893 8934/3 Carcinofibroma 8935/3 Stromal sarcoma, NOS 8936/3 Gastrointestinal stromal sarcoma
899 8990/3 Mesenchymoma, malignant 8991/3 Embryonal sarcoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

63

SMALL INTESTINE C170-C173,C178-C179 HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS

966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9717/3 Intestinal T-cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

64

SMALL INTESTINE C170-C173,C178-C179 MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9764/3 Immunoproliferative small intestinal disease 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

65

LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

66

LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199 ADENOCARCINOMA, NOS
ENDOCRINOMAS ADENOCA. IN ADENOMA. POLYP ADENOCA IN FAMIL POLYP COLI SOLID CARCINOMA, NOS CARCINOID TUMOR, MALIGNANT
BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
MUCOEPIDERMOID CARCINOMA CYSTADENOCARCINOMA, NOS

814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8145/3 Carcinoma, diffuse type 8147/3 Basal cell adenocarcinoma
815 8152/3 Glucagonoma, malignant 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
821 8210/2 Adenocarcinoma in situ in adenomatous polyp 8210/3 Adenocarcinoma in adenomatous polyp 8211/3 Tubular adenocarcinoma 8213/3 Serrated adenocarcinoma
822 8220/2 Adenocarcinoma in situ in familial polyp. coli 8220/3 Adenocarcinoma in adenoma. polyposis coli 8221/2 Adenocarc. in situ in mult. adenomatous polyps 8221/3 Adenocarcinoma in mult. adenomatous polyps
823 8230/2 Duct carcinoma in situ, solid type 8230/3 Solid carcinoma, NOS 8231/3 Carcinoma simplex
824 8240/3 Carcinoid tumor, malignant 8241/3 Enterochromaffin cell carcinoid 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8244/3 Composite carcinoid 8245/3 Adenocarcinoid tumor 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma 8265/3 Micropapillary carcinoma, NOS
843 8430/3 Mucoepidermoid carcinoma
844 8440/3 Cystadenocarcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

67

LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199 MUCINOUS ADENOCARCINOMA SIGNET RING CELL CARCINOMA MEDULLARY CARCINOMA, NOS ACINAR CELL CARCINOMA ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA
SARCOMA, NOS
FIBROMATOUS NEOPLASMS
SARCOMA, NOS LIPOSARCOMA NEOPLASMS

848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
849 8490/3 Signet ring cell carcinoma
851 8510/3 Medullary carcinoma, NOS
855 8550/3 Acinar cell carcinoma 8551/3 Acinar cell cystadenocarcinoma
856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant
882 8825/3 Myofibroblastic sarcoma
885 8850/3 Liposarcoma, NOS 8851/3 Liposarcoma, well differentiated 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed type liposarcoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

68

LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199 MYOMATOUS NEOPLASMS STROMAL SARCOMA CARCINOSARCOMA, NOS MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE

889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
893 8934/3 Carcinofibroma 8935/3 Stromal sarcoma, NOS 8936/3 Gastrointestinal stromal sarcoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

69

LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199 FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS

969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9717/3 Intestinal T-cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

70

LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199 PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

981 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

71

APPENDIX C181 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

72

APPENDIX C181 ADENOCARCINOMA, NOS
ENDOCRINOMAS ADENOCA. IN ADENOMA. POLYP ADENOCA IN FAMIL POLYP COLI SOLID CARCINOMA, NOS CARCINOID TUMOR, MALIGNANT
BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
MUCOEPIDERMOID CARCINOMA CYSTADENOCARCINOMA, NOS

814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8145/3 Carcinoma, diffuse type 8147/3 Basal cell adenocarcinoma
815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
821 8210/2 Adenocarcinoma in situ in adenomatous polyp 8210/3 Adenocarcinoma in adenomatous polyp 8211/3 Tubular adenocarcinoma
822 8220/2 Adenocarcinoma in situ in familial polyp. coli 8220/3 Adenocarcinoma in adenoma. polyposis coli 8221/2 Adenocarc. in situ in mult. adenomatous polyps 8221/3 Adenocarcinoma in mult. adenomatous polyps
823 8230/2 Duct carcinoma in situ, solid type 8230/3 Solid carcinoma, NOS 8231/3 Carcinoma simplex
824 8240/3 Carcinoid tumor, malignant 8241/3 Enterochromaffin cell carcinoid 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8244/3 Composite carcinoid 8245/3 Adenocarcinoid tumor 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
843 8430/3 Mucoepidermoid carcinoma
844 8440/3 Cystadenocarcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

73

APPENDIX C181 MUCINOUS CYSTADENOCARC., NOS MUCINOUS ADENOCARCINOMA SIGNET RING CELL CARCINOMA MEDULLARY CARCINOMA, NOS ACINAR CELL CARCINOMA ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA
SARCOMA, NOS
FIBROMATOUS NEOPLASMS
SARCOMA, NOS LIPOSARCOMA NEOPLASMS

847 8470/2 Mucinous cystadenocarcinoma, non-invasive 8470/3 Mucinous cystadenocarcinoma, NOS 8471/3 Papillary mucinous cystadenocarcinoma
848 8480/2 High grade appendiceal mucinous neoplasm 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
849 8490/3 Signet ring cell carcinoma
851 8510/3 Medullary carcinoma, NOS
855 8550/3 Acinar cell carcinoma 8551/3 Acinar cell cystadenocarcinoma
856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant
882 8825/3 Myofibroblastic sarcoma
885 8850/3 Liposarcoma, NOS 8851/3 Liposarcoma, well differentiated 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/3 Pleomorphic liposarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

74

APPENDIX C181 LIPOSARCOMA NEOPLASMS MYOMATOUS NEOPLASMS STROMAL SARCOMA CARCINOSARCOMA, NOS MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE

885 8855/3 Mixed type liposarcoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
893 8934/3 Carcinofibroma 8935/3 Stromal sarcoma, NOS 8936/3 Gastrointestinal stromal sarcoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

75

APPENDIX C181 FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS

969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9717/3 Intestinal T-cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

76

APPENDIX C181 PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

981 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

77

RECTUM C209 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

78

RECTUM C209 TRANSITIONAL CELL CARCINOMA, NOS
ADENOCARCINOMA, NOS
ADENOCA. IN ADENOMA. POLYP ADENOCA IN FAMIL POLYP COLI SOLID CARCINOMA, NOS CARCINOID TUMOR, MALIGNANT
BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS

812 8120/2 Transitional cell carcinoma in situ 8120/3 Transitional cell carcinoma, NOS 8121/3 Schneiderian carcinoma 8122/3 Trans. cell carcinoma, spindle cell 8123/3 Basaloid carcinoma 8124/3 Cloacogenic carcinoma
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8145/3 Carcinoma, diffuse type 8147/3 Basal cell adenocarcinoma
821 8210/2 Adenocarcinoma in situ in adenomatous polyp 8210/3 Adenocarcinoma in adenomatous polyp 8211/3 Tubular adenocarcinoma 8213/3 Serrated adenocarcinoma
822 8220/2 Adenocarcinoma in situ in familial polyp. coli 8220/3 Adenocarcinoma in adenoma. polyposis coli 8221/2 Adenocarc. in situ in mult. adenomatous polyps 8221/3 Adenocarcinoma in mult. adenomatous polyps
823 8230/2 Duct carcinoma in situ, solid type 8230/3 Solid carcinoma, NOS 8231/3 Carcinoma simplex
824 8240/3 Carcinoid tumor, malignant 8241/3 Enterochromaffin cell carcinoid 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8244/3 Composite carcinoid 8245/3 Adenocarcinoid tumor 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma 8265/3 Micropapillary carcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

79

RECTUM C209 MUCOEPIDERMOID CARCINOMA CYSTADENOCARCINOMA, NOS MUCINOUS ADENOCARCINOMA SIGNET RING CELL CARCINOMA MEDULLARY CARCINOMA, NOS ACINAR CELL CARCINOMA ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA
NEVI & MELANOMAS
AMELANOTIC MELANOMA MAL. MEL. IN JUNCT. NEVUS
MAL. MELAN. IN GIANT PIGMT. NEVUS EPITHELIOID CELL MELANOMA

843 8430/3 Mucoepidermoid carcinoma
844 8440/3 Cystadenocarcinoma, NOS
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
849 8490/3 Signet ring cell carcinoma
851 8510/3 Medullary carcinoma, NOS
855 8550/3 Acinar cell carcinoma 8551/3 Acinar cell cystadenocarcinoma
856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma
872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
873 8730/3 Amelanotic melanoma
874 8743/3 Superficial spreading melanoma 8745/3 Desmoplastic melanoma, malignant 8746/3 Mucosal lentiginous melanoma
876 8761/3 Mal. melanoma in giant pigmented nevus
877 8770/3 Mixed epithel. & spindle cell melanoma 8771/3 Epithelioid cell melanoma 8772/3 Spindle cell melanoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

80

RECTUM C209 SARCOMA, NOS
FIBROMATOUS NEOPLASMS SARCOMA, NOS LIPOSARCOMA NEOPLASMS
MYOMATOUS NEOPLASMS STROMAL SARCOMA CARCINOSARCOMA, NOS MALIGNANT LYMPHOMA, NOS

880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
881 8810/3 Fibrosarcoma, NOS 8811/3 Fibromyxosarcoma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/3 Solitary fibrous tumor, malignant
882 8825/3 Myofibroblastic sarcoma
885 8850/3 Liposarcoma, NOS 8851/3 Liposarcoma, well differentiated 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed type liposarcoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
893 8934/3 Carcinofibroma 8935/3 Stromal sarcoma, NOS 8936/3 Gastrointestinal stromal sarcoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

81

RECTUM C209 HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER. ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH.

965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9717/3 Intestinal T-cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

82

RECTUM C209 PLASMA CELL TUMORS
MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

83

ANAL CANAL & ANUS C210-C212,C218 NEOPLASM CARCINOMA, NOS CARCINOMA, UNDIFF., NOS SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS
TRANSITIONAL CELL CARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8077/2 Squamous intraepithelial neoplasia, grade III 8078/3 Squamous cell carcinoma with horn formation
812 8120/2 Transitional cell carcinoma in situ 8120/3 Transitional cell carcinoma, NOS 8121/3 Schneiderian carcinoma 8122/3 Trans. cell carcinoma, spindle cell 8123/3 Basaloid carcinoma 8124/3 Cloacogenic carcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

84

ANAL CANAL & ANUS C210-C212,C218 ADENOCARCINOMA, NOS
ENDOCRINOMAS ADENOCA. IN ADENOMA. POLYP CARCINOID TUMOR, MALIGNANT
BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
MUCOEPIDERMOID CARCINOMA MUCINOUS ADENOCARCINOMA DUCT CARCINOMA
PAGET DISEASE, EXTRAMAMMARY

814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8145/3 Carcinoma, diffuse type 8147/3 Basal cell adenocarcinoma
815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
821 8210/2 Adenocarcinoma in situ in adenomatous polyp 8210/3 Adenocarcinoma in adenomatous polyp 8215/3 Adenocarcinoma of anal glands
824 8240/3 Carcinoid tumor, malignant 8241/3 Enterochromaffin cell carcinoid 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8244/3 Composite carcinoid 8245/3 Adenocarcinoid tumor 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
843 8430/3 Mucoepidermoid carcinoma
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
850 8500/2 Intraductal carcinoma, noninfiltrating, NOS 8500/3 Invasive carcinoma of no special type 8503/2 Noninfiltrating intraductal papillary adenocarcinoma 8503/3 Intraductal papillary adenocarcinoma with invasion 8504/2 Noninfiltrating intracystic carcinoma 8504/3 Intracystic carcinoma, NOS
854 8542/3 Paget disease, extramammary

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

85

ANAL CANAL & ANUS C210-C212,C218 ADENOSQUAMOUS CARCINOMA ADENOCA. WITH METAPLASIA
NEVI & MELANOMAS AMELANOTIC MELANOMA MAL. MEL. IN JUNCT. NEVUS EPITHELIOID CELL MELANOMA SARCOMA, NOS
MYOMATOUS NEOPLASMS MALIGNANT LYMPHOMA, NOS

856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma
857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma
872 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/3 Balloon cell melanoma 8723/3 Malignant melanoma, regressing
873 8730/3 Amelanotic melanoma
874 8743/3 Superficial spreading melanoma 8745/3 Desmoplastic melanoma, malignant 8746/3 Mucosal lentiginous melanoma
877 8770/3 Mixed epithel. & spindle cell melanoma 8771/3 Epithelioid cell melanoma 8772/3 Spindle cell melanoma, NOS
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

86

ANAL CANAL & ANUS C210-C212,C218 HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER. ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH.

965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9717/3 Intestinal T-cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

87

ANAL CANAL & ANUS C210-C212,C218 PLASMA CELL TUMORS
MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

88

LIVER C220 NEOPLASM
CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA
ADENOCARCINOMA, NOS ENDOCRINOMAS CHOLANGIOCARCINOMA HEPATOCELLULAR CARCINOMA, NOS
COMB HEPATOCEL CA. & CHOLANG TRABECULAR ADENOCARCINOMA

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
816 8160/3 Cholangiocarcinoma 8161/3 Bile duct cystadenocarcinoma
817 8170/3 Hepatocellular carcinoma, NOS 8171/3 Hepatocellular carcinoma, fibrolamellar 8172/3 Hepatocellular carcinoma, scirrhous 8173/3 Hepatocellular carcinoma, spindle cell variant 8174/3 Hepatocellular carcinoma, clear cell type 8175/3 Hepatocellular carcinoma, pleomorphic type
818 8180/3 Comb. hepatocel. carcinoma & cholangiocarcinoma
819 8190/3 Trabecular adenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

89

LIVER C220 CARCINOID TUMOR, MALIGNANT BRONCHIOLO-ALVEOLAR ADENOCA. CLEAR CELL ADENOCARCINOMA, NOS MUCINOUS CYSTADENOCARC., NOS MUCINOUS ADENOCARCINOMA DUCT CARCINOMA
SARCOMA, NOS
MYOMATOUS NEOPLASMS
HEPATOBLASTOMA CARCINOSARCOMA, NOS MESENCHYMOMA, MALIGNANT

824 8240/3 Carcinoid tumor, malignant 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
831 8310/3 Clear cell adenocarcinoma, NOS
847 8470/2 Mucinous cystadenocarcinoma, non-invasive 8470/3 Mucinous cystadenocarcinoma, NOS
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
850 8500/2 Intraductal carcinoma, noninfiltrating, NOS 8500/3 Invasive carcinoma of no special type 8501/2 Comedocarcinoma, non-infiltrating 8501/3 Comedocarcinoma, NOS 8503/2 Noninfiltrating intraductal papillary adenocarcinoma 8503/3 Intraductal papillary adenocarcinoma with invasion 8504/2 Noninfiltrating intracystic carcinoma 8504/3 Intracystic carcinoma, NOS 8507/2 Intraductal micropapillary carcinoma 8508/3 Cystic hypersecretory carcinoma
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
897 8970/3 Hepatoblastoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
899 8991/3 Embryonal sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

90

LIVER C220 BLOOD VESSEL TUMORS HEMANGIOENDOTHELIOMA MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.
ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS
T-CELL LYMPHOMAS

912 9120/3 Hemangiosarcoma 9124/3 Kupffer cell sarcoma
913 9130/3 Hemangioendothelioma, malignant 9133/3 Epithelioid hemangioendothelioma, malignant
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

91

LIVER C220 OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS

971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9716/3 Hepatosplenic gamma-delta cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

92

LIVER C220 PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

93

INTRAHEPATICBILE DUCTS C221 NEOPLASM
CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS GIANT & SPINDLE CELL CARCINOMA
ADENOCARCINOMA, NOS CHOLANGIOCARCINOMA HEPATOCELLULAR CARCINOMA, NOS
COMB HEPATOCEL CA. & CHOLANG TRABECULAR ADENOCARCINOMA

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
803 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8147/3 Basal cell adenocarcinoma
816 8160/3 Cholangiocarcinoma 8161/3 Bile duct cystadenocarcinoma 8162/3 Klatskin tumor
817 8170/3 Hepatocellular carcinoma, NOS 8171/3 Hepatocellular carcinoma, fibrolamellar 8172/3 Hepatocellular carcinoma, scirrhous 8173/3 Hepatocellular carcinoma, spindle cell variant 8174/3 Hepatocellular carcinoma, clear cell type 8175/3 Hepatocellular carcinoma, pleomorphic type
818 8180/3 Comb. hepatocel. carcinoma & cholangiocarcinoma
819 8190/3 Trabecular adenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

94

INTRAHEPATICBILE DUCTS C221 BRONCHIOLO-ALVEOLAR ADENOCA. CLEAR CELL ADENOCARCINOMA, NOS MUCINOUS ADENOCARCINOMA DUCT CARCINOMA
SARCOMA, NOS
MYOMATOUS NEOPLASMS
CARCINOSARCOMA, NOS BLOOD VESSEL TUMORS HEMANGIOENDOTHELIOMA MALIGNANT LYMPHOMA, NOS

825 8255/3 Adenocarcinoma with mixed subtypes
831 8310/3 Clear cell adenocarcinoma, NOS
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
850 8500/2 Intraductal carcinoma, noninfiltrating, NOS 8500/3 Invasive carcinoma of no special type 8501/2 Comedocarcinoma, non-infiltrating 8501/3 Comedocarcinoma, NOS 8503/2 Noninfiltrating intraductal papillary adenocarcinoma 8503/3 Intraductal papillary adenocarcinoma with invasion 8504/2 Noninfiltrating intracystic carcinoma 8504/3 Intracystic carcinoma, NOS 8507/2 Intraductal micropapillary carcinoma 8508/3 Cystic hypersecretory carcinoma
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
912 9120/3 Hemangiosarcoma
913 9130/3 Hemangioendothelioma, malignant 9133/3 Epithelioid hemangioendothelioma, malignant
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

95

INTRAHEPATICBILE DUCTS C221 HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER. ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA PRECURS. CELL LYMPHOBLASTIC LYMPH.

965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9716/3 Hepatosplenic gamma-delta cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

96

INTRAHEPATICBILE DUCTS C221 PLASMA CELL TUMORS
MAST CELL TUMORS NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS
IMMUNOPROLIFERATIVE DISEASES PRECURSOR LYMPHOID NEOPLASMS
LYMPHOID LEUKEMIA, NOS PROLYMPH/PRECURS LEUKEMIA CHRONIC MYELOPROLIFERATIVE DIS. MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease
975 9750/3 Malignant histiocytosis 9751/3 Langerhans cell histiocytosis, NOS 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor
976 9766/3 Lymphomatoid granulomatosis, grade 3
981 9811/3 B lymphoblastic leukemia/lymphoma, NOS 9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1 9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged 9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1) 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL) 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) 9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like
982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
983 9831/3 T-cell large granular lymphocytic leukemia 9837/3 T lymphoblastic leukemia/lymphoma
996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
997 9971/3 Polymorphic PTLD 9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

97

GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249 NEOPLASM CARCINOMA, NOS
CARCINOMA, UNDIFF., NOS SMALL CELL CARCINOMA, NOS PAPILLARY CARCINOMA, NOS SQUAMOUS CELL CARCINOMA, NOS
ADENOCARCINOMA, NOS

800 8000/3 Neoplasm, malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/3 Malignant tumor, clear cell type
801 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma
802 8020/3 Carcinoma, undifferentiated type, NOS 8021/3 Carcinoma, anaplastic type, NOS 8022/3 Pleomorphic carcinoma
804 8041/3 Small cell carcinoma, NOS 8043/3 Small cell carcinoma, fusiform cell
805 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/3 Verrucous carcinoma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma
807 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8071/3 Sq. cell carcinoma, keratinizing, NOS 8072/3 Sq. cell carcinoma, lg. cell, non-ker. 8073/3 Sq. cell carcinoma, sm. cell, non-ker. 8074/3 Sq. cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Sq. cell carc. in situ with question. stromal invas. 8076/3 Sq. cell carcinoma, micro-invasive 8078/3 Squamous cell carcinoma with horn formation
814 8140/2 Adenocarcinoma in situ 8140/3 Adenocarcinoma, NOS 8141/3 Scirrhous adenocarcinoma 8143/3 Superficial spreading adenocarcinoma 8144/2 Intestinal-type adenoma, high grade 8144/3 Adenocarcinoma, intestinal type 8147/3 Basal cell adenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

98

GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249 ENDOCRINOMAS CHOLANGIOCARCINOMA
CARCINOID TUMOR, MALIGNANT BRONCHIOLO-ALVEOLAR ADENOCA. PAPILLARY ADENOCARCINOMA, NOS
CLEAR CELL ADENOCARCINOMA, NOS MUCINOUS CYSTADENOCARC., NOS MUCINOUS ADENOCARCINOMA SIGNET RING CELL CARCINOMA DUCT CARCINOMA
ADENOSQUAMOUS CARCINOMA

815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
816 8160/3 Cholangiocarcinoma 8161/3 Bile duct cystadenocarcinoma 8162/3 Klatskin tumor 8163/3 Pancreatobiliary-type carcinoma
824 8240/3 Carcinoid tumor, malignant 8246/3 Neuroendocrine carcinoma 8249/3 Neuroendocrine tumor
825 8255/3 Adenocarcinoma with mixed subtypes
826 8260/3 Papillary adenocarcinoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma
831 8310/3 Clear cell adenocarcinoma, NOS
847 8470/3 Mucinous cystadenocarcinoma, NOS
848 8480/3 Mucinous adenocarcinoma 8481/3 Mucin-producing adenocarcinoma
849 8490/3 Signet ring cell carcinoma
850 8500/2 Intraductal carcinoma, noninfiltrating, NOS 8500/3 Invasive carcinoma of no special type 8501/2 Comedocarcinoma, non-infiltrating 8501/3 Comedocarcinoma, NOS 8503/2 Noninfiltrating intraductal papillary adenocarcinoma 8503/3 Intraductal papillary adenocarcinoma with invasion 8504/2 Noninfiltrating intracystic carcinoma 8504/3 Intracystic carcinoma, NOS 8507/2 Intraductal micropapillary carcinoma 8508/3 Cystic hypersecretory carcinoma
856 8560/3 Adenosquamous carcinoma 8562/3 Epithelial-myoepithelial carcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

99

GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249 ADENOCA. WITH METAPLASIA
SARCOMA, NOS
MYOMATOUS NEOPLASMS RHABDOMYOSARCOMA, NOS CARCINOSARCOMA, NOS MALIGNANT LYMPHOMA, NOS HODGKIN LYMPHOMA
HODGKIN LYMPHOMA, NOD. SCLER.

857 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma w cartilag. & oss. metaplas. 8572/3 Adenocarcinoma with spindle cell mataplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differen. 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma
880 8800/3 Sarcoma, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor
889 8890/3 Leiomyosarcoma, NOS 8891/3 Epithelioid leiomyosarcoma 8894/3 Angiomyosarcoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma
890 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma
898 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal type 8982/3 Malignant myoepithelioma
959 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin 9596/3 Composite Hodgkin and non-Hodgkin lymphoma
965 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS 9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular 9659/3 Hodgkin lymph., nodular lymphocyte predom.
966 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nod. scler., cellular phase 9665/3 Hodgkin lymphoma, nod. scler., grade 1

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022

100

GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249 HODGKIN LYMPHOMA, NOD. SCLER. ML, SMALL B-CELL LYMPHOCYTIC ML, LARGE B-CELL, DIFFUSE FOLLIC. & MARGINAL LYMPH, NOS
T-CELL LYMPHOMAS OTHER SPEC. NON-HODGKIN LYMPHOMA
PRECURS. CELL LYMPHOBLASTIC LYMPH. PLASMA CELL TUMORS
MAST CELL TUMORS

966 9667/3 Hodgkin lymphoma, nod. scler., grade 2
967 9670/3 ML, small B lymphocytic, NOS 9671/3 ML, lymphoplasmacytic 9673/3 Mantle cell lymphoma 9675/3 ML, mixed sm. and lg. cell, diffuse
968 9680/3 ML, large B-cell, diffuse 9684/3 ML, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell histiocyte rich large B-cell lymphoma
969 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS
970 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma
971 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9716/3 Hepatosplenic gamma-delta cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type
972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9728/3 Precursor B-cell lymphoblastic lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma
973 9731/3 Plasmacytoma, NOS 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
974 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9749/3 Erdhiem-Chester Disease

